Chronic Myelomonocytic Leukemia (CMML) and Juvenile Myelomonocytic Leukemia (JMML)
Your order contains item(s)
View Order
This fact sheet provides information about the diagnosis, treatment, clinical trials, expected outcomes and support resources for chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML).
Excerpt
Chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) are uncommon blood cancers that are classified by the World Health Organization (WHO) as "mixed myelodysplastic/myeloproliferative diseases." CMML and JMML each start with one or more acquired changes (mutations) to the DNA of a single cell called a "monocyte" (a type of blood cell).
